{"entity":{"id":"paper-vallely-hpv-stat-png-lancetgh-2022","kind":"paper","name":"Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea (HPV-STAT)","aka":[],"tldr":"In 4,285 women in Papua New Guinea who took their own vaginal sample for a point-of-care HPV test, 93% of those who tested positive were treated with thermal ablation the same day, and the strategy detected 85% of high-grade lesions.","summary":"HPV-STAT was a large single-arm intervention trial at two clinical sites in Papua New Guinea, from June 2018 to January 2020. Women aged 30 to 59 self-collected a vaginal specimen for point-of-care GeneXpert HPV testing; those who tested positive had a pelvic examination and same-day thermal ablation or referral. The authors call it the first real-world evaluation of a fully integrated self-collect, test and treat strategy for same-day cervical screening in a low- or middle-income country. Registered as ISRCTN13476702 and funded by Australia's National Health and Medical Research Council.","asOf":"2026-11-11","links":[{"label":"DOI","url":"https://doi.org/10.1016/S2214-109X(22)00271-6"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/35878625/"}],"tags":[],"related":[],"cancers":["cervical"],"sections":[],"technologies":["hpv-testing","precancer-ablation"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"The Lancet Global Health","year":2022,"doi":"10.1016/S2214-109X(22)00271-6","pmid":"35878625","authors":"Vallely AJB, Saville M, Badman SG, et al.","paperType":"real-world","findings":["4,285 women were recruited; 647 (15.1%) tested positive for one or more oncogenic HPV types.","Sensitivity for high-grade squamous intraepithelial lesion or worse was 85.4% (95% CI 81.0 to 89.6), specificity 89.6%, positive predictive value 35.2% and negative predictive value 98.9%.","602 of the HPV-positive women (93.0%) received same-day thermal ablation; 42 were referred for gynaecology review and 37 of them attended.","Of 329 women seen at 3 months, 51 (15.5%) reported mild symptoms that had resolved; there were no serious adverse events."],"whatItMeans":"A woman in Papua New Guinea can take her own sample, get the result and, if needed, be treated in a single visit.","caveats":["Two clinics with an on-site consultant gynaecologist, chosen with health authorities; results at less well staffed sites may differ.","Single-arm design, without a comparison group in the same trial."],"participants":4285},"route":"/key-papers/paper-vallely-hpv-stat-png-lancetgh-2022/","neighbours":{"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"}],"technology":[{"id":"hpv-testing","kind":"technology","name":"HPV DNA testing and self-sampling","route":"/technologies/hpv-testing/"},{"id":"precancer-ablation","kind":"technology","name":"Thermal ablation and cryotherapy for cervical precancer","route":"/technologies/precancer-ablation/"}],"institution":[{"id":"png-national-department-of-health","kind":"institution","name":"National Department of Health, Papua New Guinea","route":"/institutions/png-national-department-of-health/"}]}}